Skip to main content
SpringerLink
Log in

Phase II study of fazarabine in advanced head and neck cancer

A Southwest Oncology Group Study

  • Clinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Veseley J, Piskala A: Mechanism of action of 1-B-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells. Neoplasma 33(1):3–10, 1986

    Google Scholar 

  2. Townsend A, Leclerc JM, Dutschman G, Cooney D, Cheng, Y: Metabolism of 1-B-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4). Cancer Res 45:3522–3528, 1985

    Google Scholar 

  3. Glazer RI, Knode MC: 1-B-D-arabinosyl-5-azacytosine: cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells. Mol Pharmacol 26:381–387, 1984

    Google Scholar 

  4. Dalal M, Plowman J, Breitman TR, Schuller HM, Del Campo AA, Vistica DT, Driscoll JS, Cooney DA, Johns DG: Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties. Cancer Res 46:831–838, 1986

    Google Scholar 

  5. Driscoll JS, John DG, Plowman J: Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia. Invest New Drugs 3:331–334, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Oklahoma Health Center, Oklahoma City, OK, USA

    J. Philip Kuebler

  2. Southwest Oncology Group Statistical Center, Seattle, WA, USA

    Barbara Metch

  3. Ohio State University Health Center, Columbus, OH, USA

    David E. Schuller

  4. John L. McClellan VA Hospital, Little Rock, AR, USA

    Michael Keppen

  5. Wichita CCOP, KS, USA

    Harry E. Hynes

Authors
  1. J. Philip Kuebler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Metch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David E. Schuller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Keppen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harry E. Hynes
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Address for offprints: Southwest Oncology Group (SWOG-8912), Operations Office, 5430 Fredricksburg Road, Suite-618, San Antonio, TX 78229-6197, USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuebler, J.P., Metch, B., Schuller, D.E. et al. Phase II study of fazarabine in advanced head and neck cancer. Invest New Drugs 9, 373–374 (1991). https://doi.org/10.1007/BF00183585

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00183585

key words

Search

Navigation